Defining the Role of Expanded Access in Rare Diseases from Concept to Readiness

  • Exploring where expanded access delivers the greatest value within rare disease development and patient access strategies
  • Preparing operationally and regulatorily for expanded access programmes prior to launch
  • Aligning expanded access with broader regulatory pathways and evidentiary expectations
  • Understanding the role of expanded access beyond data generation focusing on patient need and access equity